HER2(YVMA) drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy

Mutations in the HER2 kinase domain have been identified in human clinical lung cancer specimens. Here we demonstrate that inducible expression of the most common HER2 mutant (HER2(YVMA)) in mouse lung epithelium causes invasive adenosquamous carcinomas restricted to proximal and distal bronchioles....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Perera, Samanthi A., Li, Danan, Shimamura, Takeshi, Raso, Maria G., Ji, Hongbin, Chen, Liang, Borgman, Christa L., Zaghlul, Sara, Brandstetter, Kathleyn A., Kubo, Shigeto, Takahashi, Masaya, Chirieac, Lucian R., Padera, Robert F., Bronson, Roderick T., Shapiro, Geoffrey I., Greulich, Heidi, Meyerson, Matthew, Guertler, Ulrich, Chesa, Pilar Garin, Solca, Flavio, Wistuba, Ignacio I., Wong, Kwok-Kin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2009
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2626727/
https://ncbi.nlm.nih.gov/pubmed/19122144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0808930106
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak